NOV
Novo Nordisk A/S Class B · XETR:NOV
35.77 EUR0.0600 +0.17%
1-year price target
40.98 EUR
+14.56% from the last price (35.77)
High61.01
Median39.52
Low26.70
Analyst ratings
Based on 34 analysts.
Strong buy9
Buy0
Hold17
Sell3
Strong sell5
Estimates
| Last quarter | Estimate | Next quarter | Next year | |
|---|---|---|---|---|
| EPS (USD) | 0.9418 | 0.7666 | 0.7188 | 3.46 |
| Revenue (USD) | 11.96 B | 10.87 B | 11.12 B | 47.34 B |
Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.